IASO Biotherapeutics (IASO Bio), a biopharmaceutical company that discovers, develops, manufactures, and markets innovative cell therapies and antibody products, announced a new set of collaborations with Umoja Biopharma, Inc. (Umoja)...
BridGene Biosciences, Inc., a leader in small molecule drug development targeting conventional "hard-to-drug" targets, announced a strategic collaboration and license arrangement with Galapagos NV. Under the collaboration, BridGene will use its...
The US Food and Drug Administration (FDA) has approved OBI Pharma's investigational new drug (IND) application for OBI-992, allowing the company to move forward with a phase 1/2 study of its innovative antibody-drug conjugate (ADC) cancer therapy...
According to two persons familiar with the situation, Quadria Capital, an Asia-focused private equity fund, is in advanced talks to acquire a significant minority position in India's largest dialysis chain, NephroPlus, for 2,000 crore...
Empassion Health and Theoria Medical announced a strategic alliance today that will benefit their patients across the country by offering additional treatment and services, cutting out-of-pocket costs, and increasing the number of lives touched by...
WuXi XDC announced the signing of a Memorandum of Understanding (MoU) for a comprehensive collaboration in drug-linker technology and CRDMO services spanning from discovery to commercialization. Dr. Jimmy Li, CEO of WuXi XDC, commented...
Suzhou Ribo Life Science Co., Ltd. and Ribocure AB collaborate with Boehringer Ingelheim to discover innovative treatments for steatohepatitis caused by nonalcoholic or metabolic dysfunction. The collaboration combines Ribo's expertise in the...
Dr. Reddy's purchased Amyris' MenoLabs business, a prominent women's health and dietary supplement branded portfolio, for $3 million in a Chapter 11 bankruptcy action in the United States Bankruptcy Court for the District of Delaware. Dr. Reddy’s...
Alembic Pharmaceuticals Limited has gained FDA approval for eight of its Abbreviated New Drug Applications (ANDA) in Q3FY24. The company has received five final approvals that includes selexipag tablets, 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,400...
Glenmark Pharmaceuticals Ltd. (Glenmark), a worldwide pharmaceutical business focused on research, has introduced a biosimilar of the popular anti-diabetic medicine liraglutide in India for the first time. Following permission from the medicine...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")